
==== Front
BMC Cardiovasc Disord
BMC Cardiovasc Disord
BMC Cardiovascular Disorders
1471-2261
BioMed Central London

4185
10.1186/s12872-024-04185-3
Research
The effect of early initiation of self-management program based on multidisciplinary education in heart failure patients
Jia Na 1
Zhao Yajie 1
Sun Xuelin 2
Wang Mingfang 3
Guo Di guodi3878@bjhmoh.cn

1
1 grid.506261.6 0000 0001 0706 7839 Cardiology Department, Beijing Hospital, National Center of Gerontology, National Health Commission Institute of Geriatric medicine, Chinese Academy of medical sciences, Beijing, China
2 grid.506261.6 0000 0001 0706 7839 Pharmacology Department, Beijing Hospital, National Center of Gerontology, National Health Commission Institute of Geriatric medicine, Chinese Academy of medical sciences, Beijing, China
3 grid.506261.6 0000 0001 0706 7839 Nutrition Department, Beijing Hospital, National Center of Gerontology, National Health Commission Institute of Geriatric medicine, Chinese Academy of medical sciences, Beijing, China
19 9 2024
19 9 2024
2024
24 50316 3 2024
11 9 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by-nc-nd/4.0/ Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
Aims

To explore the effect of early initiation of self-management based on multidisciplinary education in heart failure (HF) patients.

Methods

HF patients in the Cardiology Department of Beijing Hospital were consecutively enrolled from June 2022 to February 2023. In-hospital HF patients from June 2022 to October 2022 were divided into the control group, and HF patients from November 2022 to February 2023 were divided into the cardiac rehabilitation (CR) group. A series of self-management education sessions with cardiologists, pharmacologists, nutritionists, and nurses was initiated early in the CR group. Continuous strengthening education was provided during the 3 months of discharge. Patients in the control group only received education twice during hospitalization. Minnesota Living with Heart Failure Questionnaire (MLHFQ), Pittsburgh sleep quality index (PSQI), anxiety Self-rating anxiety scale (SAS), and Self-rating depression scale (SDS) were compared between the two groups. Major cardiovascular adverse events (MACEs) were recorded during follow-up.

Results

A total of 91 HF patients were enrolled. There were 44 patients in the CR group and 47 in the control group. Compared with before the program, the MLHFQ and SAS scores significantly decreased at 3 months after discharge in both groups. PSQI also showed mild improvement without significant differences in both groups. Furthermore, SDS showed a significant increase in the CR group but within the normal range. MACE occurrences did not show a significant difference.

Conclusion

Early initiation of self-management program based on multidisciplinary education may help improve quality of life, sleep quality, and reduce anxiety for hospitalized HF patients.

Keywords

Cardiac rehabilitation
Heart failure
Self management
Patient education
National High Level Hospital Clinical Research FundingBJ-2023-137 BJ-2021-215 issue-copyright-statement© BioMed Central Ltd., part of Springer Nature 2024
==== Body
pmcIntroduction

Heart failure (HF) is a clinical syndrome due to any structural or functional abnormalities that affect ventricular filling and ejection [1]. Consequently, HF has a high incidence, mortality, and readmission rate, which seriously endangers human health [2]. According to the registry data of the American Heart Association (AHA), the prevalence of HF will increase by 46% between 2012 and 2030, where patients with HF who are younger than 65 years old will have a 6 to 9 times greater risk of experiencing sudden cardiac death when compared with that of the general population [3]. Moreover, a 2003 Chinese survey showed that the HF incidence in adults aged 35–74 was 0.9%. Notably, the annual incidence is on the rise [4]. Another Chinese survey indicated the in-hospital mortality of HF in 1980, 1990, and 2000 was 15.4%, 12.3%, and 6.2%, respectively [5, 6].

Guidelines emphasize that cardiac rehabilitation (CR) should be initiated soon after stabilization of acute HF to optimize target medication, improve volume management, and increase self-care ability [1, 7, 8]. Effective self-management is essential for ensuring stable medical conditions, maintaining functional status, and returning to work [9]. However, HF patients often lack health awareness, good compliance, and self-management skills. Additionally, self-management requires a certain amount of time [10]. Thus, self-management program is nesseray to help HF patients master their self-care skills. Notably, some previous studies have focused on promoting self-management skills in HF patients following discharge [11–13]. However, self-managemen program is supposed to inicaite as early as possible and detailed contents is needed to explore. Therefore, this study aims to explore new self-management approaches in HF patients and evaluate the effects on quality of life, sleep quality, psychological status, and major cardiovascular events (MACEs). As such, we expect to provide new ideas and methods for self-care of HF patients.

Methods

Patient enrollment

Patients were consecutively enrolled in the Cardiology Department of Beijing Hospital from June 2022 to May 2023. Inclusion criteria included: (i) Diagnosis of HF according to Chinese guidelines for diagnosis and treatment of heart failure 2018 [6]; (ii) Stage II to IV of heart function according to New York Heart Association (NYHA); (iii) Ability to independently complete questionnaire; (iv) Signed written informed consent. Exclusion criteria included: (i) Unconsciousness or cognitive impairment; (ii) Severe infection; (iii) Severe liver and kidney dysfunction; (iv) End-stage tumor. HF patients admitted from June 2022 to August 2022 were divided into the control group; those admitted from September 2022 to February 2023 were divided into the CR group. The self-management program lasted 3 months. Furthermore, our study agreed with the Declaration of Helsinki and the laws and regulations related to ethical review. The Ethical Committee of Beijing Hospital approved this study (2022BJYYEC-011-02). All the participants signed the informed consent.

Self-management program on CR

The early self-management program on CR was initiated 1–2 days following admission. As such, cardiologists evaluated the patient’s disease condition, quality of life, sleep quality, and psychological status to develop an individualized CR plan. Then, educational handbooks were delivered to the patients. Moreover, nurses guided patients in joining the WeChat group.

Multiple educational programs were conducted from the 3rd day to the 1st day before discharge. The pharmacists explained the type, single dose, and frequency of drugs to the patients and informed them of the precautions for taking medication. Nutritionists evaluated the patients’ nutritional status and dietary habits and guided them in ordering meals. Additionally, nurses used food models to educate on volume management content. They provided water content tables for common foods, assisted patients in body weighing in the morning, and recorded daily intake and output volume. Cardiologists used the self-rating anxiety and depression scale to evaluate the psychological status of patients. They encouraged patients to maintain an optimistic mood, promoting their confidence in disease coping. For patients with clear anxiety and depression, psychological consultation was preceded. Nurses provided face-to-face self-management education twice during hospitalization, every 30 min, mainly focusing on HF knowledge, self-weight measurement, symptom control, water and salt intake restriction, dietary advice, and exercise suggestions. A CR package was given to the patients before discharge, including a calibrated weight scale, graduated counting cup, and salt spoon, explaining the usage of the package.

Self-management skills were enhanced from the day of discharge to 3 months of discharge. Short scientific articles were pushed weekly through the Wechat group, mainly around HF knowledge, medications, exercise, diet, and symptom recognition. Symptoms, intake and output volume, body weight, and daily activities were followed up every two weeks through phone visits. Physicians adjusted diuretic dosage as needed.

Patients in the control group only received two instances of education during hospitalization. The content of education was the same as that of the CR group. Patients also joined the same WeChat group and received weekly short scientific articles. Follow-ups were also provided every 2 weeks through phone calls.

Data collection

Quality of life

Quality of life was investigated using the Minnesota Living with Heart Failure Questionnaire (MLHFQ) [14]. The questionnaire contained 21 items, covering the physical dimension (8 items), emotional dimension (5 items), and other dimension (8 items). Each item ranged from 0 to 5 points, and the total score ranged from 0 to 105 points by adding up the scores of each item. The higher scores indicated a poorer quality of life.

Quality of sleep

Buysse et al. developed the Pittsburgh Sleep Quality Index (PSQI) in 1989 to assess participants’ sleep quality in the past month [15]. There were 19 self-evaluation items and 5 other evaluation items on the scale. Each factor was scored on a 0–3 scale. The cumulative score of each factor was the total score of PSQI, with a range of 0–21. The higher the score, the worse the sleep quality.

Anxiety and depression assessment

The self-rating Anxiety Scale (SAS) contained 20 items that reflect anxiety feelings [16]. Each item was rated at four levels based on the frequency of symptom occurrence. Fifteen questions were rated positively, and 5 questions were rated negatively. A higher score indicated severe anxiety. The self-rating Depression Scale (SDS) consisted of 20 items that reflect depression feelings [17]. Each item was rated at four levels based on the frequency of symptom occurrence. Ten questions were rated positively, and 10 questions were rated negatively. A higher score indicated severe depression.

Major cardiovascular events (MACEs)

MACEs in this study were defined composite outcomes including as acute HF exacerbation, severe electrolyte imbalance (serum sodium concentration less than 120 mmol/L or more than 160 mmol/L, and serum potassium less than 3.0 mmol/L or more than 5.5mmol/L), hypotension, cardiac readmission, and all-cause mortality. MACEs were acquired via medical record system inquiry and phone calls 30 days and 3 months of discharge.

Meassurer of data

MLHFQ and PSQI, were investigated by the two nurses during hospitalization. SAS, SDS were assessed by cardilogyists during hospitalization. Face-to-face survey was used. At 30 days and 3 months of discharge follow-up, nurses gave the phone call to the patients to investigate the four scales and MACEs. These scales were printed out in advance, recorded on paper by the nurses, and then input into a database.

Statistical analysis

Randomization and blinding were not used in this study. The sample size was calculated depending on Meng’s study [18]. Based on multiple outcomes, the total sample size was estimated to be 80 cases, with 40 cases in each group. Baseline data was described according to variable types. The Kolmogorov-Smirnow test was used to detect a normal distribution of measurement data. Normally distributed variables were presented as mean ± standard deviation. A median (Q1, Q3) was used for non-normally distributed variables. Independent sample Student’s t-test was used for continuous, normally distributed variables, and the Mann–Whitney U test was used for other metric variables in comparing two groups. The chi-square or Fisher’s exact test was used for categorical variables. In a single group comparison, paired t-tests were chosen to analyze before and after intervention. Two-way repeat measurement ANOVA was used to consider two times of measurement and different intervention for each group. Within-subjects effects and interactions were also tested. SPSS software (version 20.0; SPSS, Inc., Chicago, IL, USA) was used for statistical analyses. Two sides of P < 0.05 indicated a significant difference.

Results

Baseline characteristics

A total of 91 HF patients were finally selected from June 2022 to February 2023. Among them, 44 patients were enrolled in the CR group, while 47 patients were divided into the control group. There were 57 male patients and 34 female patients. The average age was 73.00 ± 8.51 years, ranging from 37 to 90 years. Other characteristics are shown in Table 1.

Table 1 Baseline characteristics in the CR and control groups

Items	Total (n = 91)	CR group (n = 44)	Control group (n = 47)	Statistic value	P value	
General information						
 Sex (M: F)	57: 34	27: 17	30: 17	0.059	0.832	
 Age (year)	73.00 ± 8.51	72.89 ± 7.59	73.11 ± 9.38	0.363	0.903	
 BMI (kg/m2)	25.36 ± 4.10	25.98 ± 3.72	24.96 ± 4.41	1.545	0.237	
Educational level						
 Illiteracy n (%)	3 (3.30)	0	3 (6.38)	10.525	0.032	
 Primary school n (%)	10 (10.99)	6 (1.36)	4 (8.51)	
 Junior school n (%)	42 (46.15)	26 (59.10)	16 (3.40)	
 Polytechnic school n (%)	22 (24.18)	6 (1.36)	16 (3.40)	
 University and above n (%)	14 (15.38)	6 (1.36)	8 (1.70)	
Past medical history						
 Smoking n (%)	36 (39.56)	13 (29.55)	23 (48.94)	3.574	0.059	
 Alcohol n (%)	32 (35.16)	9 (20.45)	23 (48.94)	8.086	0.008	
 Hypertension n (%)	62(68.13)	31 (70.45)	31 (65.96)	0.212	0.661	
 Coronary artery disease n (%)	30 (32.96)	12 (27.27)	18 (38.30)	1.250	0.276	
 Hyperlipidemia n (%)	44 (48.35)	18 (40.91)	26 (55.32)	1.890	0.210	
 Arrhythmia	18 (19.78)	12 (27.27)	6 (12.77)	3.014	0.115	
 Diabetes n (%)	37 (40.65)	21 (47.72)	16 (34.04)	1.764	0.206	
 Stoke n (%)	16 (17.58)	11 (25.00)	5 (10.64)	3.235	0.099	
Laboratory						
 ALT (U/L)	20.80 ± 16.23	19.09 ± 14.21	22.40 ± 17.92	1.218	0.273	
 AST (U/L)	21.37 ± 11.56	20.18 ± 10.06	22.49 ± 12.82	1.411	0.238	
 Albumin (g/L)	38.20 ± 4.20	38.45 ± 3.82	37.96 ± 4.56	0.006	0.936	
 Glucose (mmol/L)	6.94 ± 3.18	7.43 ± 3.95	6.46 ± 2.11	2.689	0.105	
 Creatinine (umol/L)	104.12 ± 74.18	103.05 ± 50.00	105.09 ± 91.08	0.274	0.602	
 Potassium (mmol/L)	4.09 ± 0.45	3.99 ± 0.44	4.18 ± 0.45	0.033	0.857	
 Sodium (mmol/L)	140.45 ± 4.40	140.74 ± 3.94	140.17 ± 4.82	0.047	0.829	
 LDL-C (mmol/L)	1.97 ± 0.67	2.12 ± 0.77	1.82 ± 0.53	10.429	0.002	
 BNP (pg/ml)	347.55 (164.89, 771.48)	389.24 (133.97, 1217.68)	296.13 (183.56, 637.48)	-0.775	0.438	
Medication						
 Anti-platelet drug n (%)	46 (50.55)	20 (45.45)	26 (55.32)	0.885	0.404	
 Anticoagulation drug n (%)	30 (32.97)	17 (38.64)	13 (27.66)	1.239	0.372	
 Β-receptor blocker n (%)	51 (56.04)	25 (56.82)	26 (55.32)	0.021	0.886	
 ACEI/ARB n (%)	61 (67.03)	30 (68.18)	31 (65.96)	0.051	0.822	
 Diuretics n (%)	60 (65.93)	31 (70.45)	29 (61.70)	0.775	0.507	
 Statins n (%)	62 (68.13)	29 (65.91)	33 (72.21)	0.194	0.822	
 Nitrites n (%)	18 (19.78)	9 (20.45)	9 (19.15)	0.024	0.876	
 SGLT2 inhibitor n (%)	32 (35.16)	21 (47.73)	11 (23.40)	5.897	0.017	
 Oral hypoglycemic drugs n (%)	19 (20.88)	10 (22.73)	9 (19.15)	0.176	0.798	
 Insulin n (%)	11 (12.09)	7 (15.91)	4 (8.51)	1.171	0.344	
Abbreviations: ACEI, angiotensin-converting enzyme inhibitor; ALB, albumin; ALT, alanine transaminase; AST, aspartate transaminase; ARB, angiotensin receptor blocker; SGLT2, sodium-dependent glucose transporters 2

Quality of life and sleep quality comparison between the CR and control groups

T test showed that MLHFQ scores significantly decreased at 3 months of discharge in both groups compared with baseline. Repeat measurement ANOVA analysis indicated that MLHFQ score had significant decrease before and after program (F = 51.557, P < 0.001), while different self-management program also showed significant difference (F = 47.503, P < 0.001). No significant difference of change of NLHFQ was detected between two management program (F = 0.015, P = 0.902) The results were shown in Tables 2 and 3; Fig. 1.

Table 2 Quality of life and sleep quality comparisons between the CR and control groups

Items	CR group n = 44	Control group n = 47	t value	P value	
MLHFQ (Admission)	17.66 ± 13.56	30.30 ± 18.14	-3.762b	< 0.001b	
MLHFQ (3 months of discharge)	5.77 ± 8.21	17.95 ± 4.34	-8.642b	< 0.001b	
t valuea	t = 5.494	t = 4.636			
P valuea	P < 0.001	P < 0.001			
PSQI (Admission)	7.23 ± 2.65	6.13 ± 2.47	2.031b	0.045b	
PSQI (3 months of discharge)	6.91 ± 2.21	5.65 ± 2.30	2.642b	0.010b	
t valuea	t = 0.541	t = 1.078			
P valuea	P = 0.591	P = 0.287			
Abbreviations: MLHFQ, Minnesota Living with Heart Failure Questionnaire; PSQI, Pittsburgh sleep quality index

a: paired t test comparison before and after program

b: independent sample t test comparison between two management program

Table 3 Repeat measurement ANOVA analysis results

Items	Effect	Sum of squares	Degree of freedom	Mean square	F value	P value	
MLHFQ	Time	6456.568	1	6456.568	51.557	<0.001	
Group	6775.364	1	6775.364	47.503	<0.001	
Interaction	2.273	1	2.273	0.015	0.902	
PSQI	Time	6.188	1	6.188	0.855	0.360	
Group	67.506	1	67.506	12.580	0.001	
Interaction	0.142	1	0.142	0.028	0.868	
SAS	Time	327.273	1	327.273	31.257	<0.001	
Group	3.273	1	3.273	0.151	0.699	
Interaction	66.273	1	66.273	5.385	0.025	
SDS	Time	16.568	1	16.568	0.391	0.535	
Group	3820.455	1	3820.455	47.098	<0.001	
Interaction	16.568	1	16.568	0.391	0.535	
Abbreviations: MLHFQ, Minnesota Living with Heart Failure Questionnaire; PSQI, Pittsburgh sleep quality index; SAS, Self-Rating Anxiety Scale; SDS, Self-Rating Depression Scale

Fig. 1 Comparison of quality of life and sleep quality between the CR and control groups. (A) Comparison of Minnesota Living with Heart Failure Questionnaire score on adimission and 3-month of discharge. (B) Comparison of Pittsburgh Sleep Quality Index score on adimission and 3-month of discharge

* indicated P < 0.05; ** indicated P < 0.01; *** indicated P < 0.001

T test indicated that PSQI score decreased to some extent at 3 months of discharge, but without significant change in both groups. Repeat measurement ANOVA analysis showed that PSQI score had significant decrease before and after program (F = 12.580, P = 0.001), but different self-management program did not show significant difference (F = 0.855, P = 0.360). No significant difference of change of PSQI was detected between two management program (F = 0.028, P = 0.868). The results were shown in Tables 2 and 3; Fig. 1.

Comparison of anxiety and depression between CR group and control group

T test indicated that SAS score significantly decreased at 3 months of discharge in both groups. (Tables 3 and 4; Fig. 2). Repeat measurement ANOVA analysis showed that SAS had significant decrease before and after program (F = 31.257, P<0.001), but different program group did not show significant difference (F = 0.151, P = 0.699). Moreover, the change of SAS was detected significant difference between two management program (F = 5.385, P = 0.025). The decrease of SAS was more significant in control group.

Table 4 Anxiety and depression comparisons between the CR and control groups

Items	CR group n = 44	Control group n = 47	t value	P value	
SAS (Admission)	33.61 ± 2.81	34.93 ± 4.04	-1.794	0.076	
SAS (3 months of discharge)	32.11 ± 5.02	31.10 ± 4.16	1.060	0.292	
	t = 2.032	t = 5.471			
	P = 0.048	P < 0.001			
SDS (Admission)	36.25 ± 4.64	36.41 ± 6.98	-0.130	0.897	
SDS (3 months of discharge)	45.45 ± 2.56	36.93 ± 6.29	8.351	< 0.001	
	t=-9.390	t=-0.390			
	P < 0.001	P = 0.698			
Abbreviations: SAS, Self-Rating Anxiety Scale; SDS, Self-Rating Depression Scale; CR, cardiac rehabilitation

Fig. 2 Comparison of anxiety and depression between CR group and control group. (A) Comparison of self-rating anxiety scale score on adimission and 3-month of discharge. (B) Comparison of self-rating anxiety scal score on adimission and 3-month of discharge

* indicated P < 0.05; ** indicated P < 0.01; *** indicated P < 0.001

T test indicated that SDS scores in the CR group were significantly increased after 3 months of program in CR groups with significantly higher than control group (Tables 3 and 4; Fig. 2). Repeat measurement ANOVA analysis showed that SDS had no significant change before and after program (F = 0.391, P = 0.535), but different program group showed significant difference (F = 47.098, P < 0.001). Furthermore, change of SDS was not detected significant difference between two management program (F = 0.391, P = 0.535).

MACEs occurrence

MACEs during follow-up at 30 days and 3 months of discharge are shown in Table 5. Notably, the rate of MACEs was not significantly different between the two groups. At 30 days of discharge, there were 2 cases of HF exacerbation. One patient was readmitted to hospital because of HF exacerbation in the CR group, while one case died becuse of severe pneumonia subsequent to septic shock in the control group. The cumulative MACEs in the CR and control groups were 4.55% and 2.12% respectively (χ2 = 0.417, P = 0.608).

Table 5 MACE comparison between the CR and control groups

Items	CR group n = 44	Control group n = 47	χ2 value	P value	
MACEs (30 days after discharge) n (%)	2 (4.55)	1 (2.12)	0.417	0.608	
HF exacerbation n (%)	2 (4.55)	0	2.092	0.242	
Electrolyte imbalance n (%)	0	0			
Hypotension n (%)	0	0			
Cardiac readmission#n (%)	1 (2.27)	0	1.057	0.489	
All-cause death n (%)	0	1 (2.13)	0.947	1.000	
MACEs (3 months after discharge) n (%)	4 (9.09)	2 (4.26)	0.580	0.678	
HF exacerbation n (%)	4 (9.10)	0	4.469	0.051	
Electrolyte imbalance n (%)	0	0			
Hypotension n (%)	0	0			
Cardiac readmission#n (%)	1 (2.27)	0	1.080	0.484	
All-cause death n (%)	0	2 (4.26)	1.914	0.495	
Abbreviations: CR, cardiac rehabilitation; HF, heart failure; MACEs, major adverse cardiovascular event

#: When the same patient had both an HF exacerbation and readmission, only one count was calculated in MACE

At 3 months of discharge, there were 4 cases of HF exacerbation, and one patient was readmitted to hospital because of HF exacerbation and 2 cases died in the CR group. Two death cases were chronnic HF pateints complicated with severe pneumonia subsequent to septic shock and renal failure. The cumulative MACEs in the CR and control groups were 9.09% and 4.26% (χ2 = 0.580, P = 0.678).

Discussions

The present study highlighted that early initiation of a self-management program based on multidisciplinary education was helpful to improve quality of life, sleep quatily and reduce anxiety. In our self-management program, we focused on training patient self-management of medication compliance, volume control, food choice, and weight monitoring.

Previous studies showed self-care education programs including self-care assessment, goal-orientated symptom recognition and response actions, fluid and dietary modification was proved to improve HF symptom, knowledge and confidence, lower risk of emergency department attendance and hospital admission, and reduced cardiovascular events [10, 19–22]. Education on symptom recognition, symptom control, diuretics adjustment, water, and dietary restrictions were the key points to improve patients’ self-care abilities [23]. Regular home visits, telephone follow-up, email, remote monitoring, and other forms could promote adherence [24]. Thus, the exploration of new approaches for patients’ self-management is important.

Fluid restriction is important for decompensated HF. Volume management education was practical to increase adherence and reduce adverse events [25, 26]. In many studies, volume management included the guidance of diuretic correct usage, identification of worsening symptoms, monitoring the side effects of drugs, limitation of sodium intake in the diet, restriction of fluid intake, daily record of body weight, and coping methods when volume overload occurs [27–29]. In our study, we prepared calibrated weight scale, counting cup, salt spoon for paitnts and educated them how to use. Although more HF exacerbation events in self-management CR group, the difference of MACEs ratio was not significant.

HF patients had higher raio of sleep disorder, including short sleep time, low sleep quality, and sleep-disordered breathing [30]. ACC/AHA guidelines identified poor sleep quality as barriers to self-care and treatment adherence in HF patients [8]. Multiple studies indicated that cognitive behavioral therapy (CBT) may help to improve sleep quality in HF patients [31–33]. Other evidence showed that in medically stable HF patients, treatment of coexisting obstructive sleep apnea by continuous positive airway pressure improved left ventricular systolic function [34, 35]. The above studies suggested that if CBT specialists and sleep experts in the team, it would be better to assist managing the patient’s sleep disorder.

A high proportion of HF patients suffer from anxiety and depression because of long-term discomfort symptoms, long-term use of multiple medications and heavy economic burden [36–38]. Anxiety and depression would irrigate the sympathetic nervous system, increase platelet activity, and lead to endothelial damage in arteries and exacerbating clinical symptoms [39]. Our results showed that after a 3-month program, the SAS score significantly decreased in both groups, while SDS score showed a significant increase in CR group. But the SAS score and SDS score were all in normal range. Possible explanations for this results were the scale inquiry in this study was completed by different person. Doctors finished the scale during hospitalization, and nurses collected the scale data during follow-up peroid. Furthermore, more diuretic usage and higher BNP levels were seen in the CR group at baseline. Those may have led to some bias in the scale score. For those HF patients with anxiety-depressive disorders, psychiatrist’s opinions are required in the self-management program.

There were some noted limitations in this study. Firstly, this was a single-center study with a small sample size, which restricted the representativeness of the samples. Secondly, in our discharge self-care package, the content of exercise training was not detailed enough. We only provided physical activity suggestions and did not conduct supervised exercise training. Lastly, we did not distinguish between ejection fractions that reduced heart failure and ejection fractions that preserved heart failure because of the limited sample size. We hope to provide new ideas for the content design of self-management programs for HF patients.

Conclusion

Early initiation of self-management program based on multidisciplinary education may help improve quality of life, sleep quality, and reduce anxiety for in-hospital HF patients.

Acknowledgements

The authors thank AiMi Academic Services (www.aimieditor.com) for English language editing and review services.

Author contributions

N.J. and D.G.; formal analysis N.J. and Y.Z.; investigation, N.J.,Y.Z. X.S. and M.W; methodology, N.J. and D.G.; writing-original draft, N.J.; writing-review and editing, X.S, M.W and D.G. All authors have read and agreed to the published version of the manuscript.

Funding

National High Level Hospital Clinical Research Funding (BJ-2021-215, BJ-2023-212, BJ-2023-137).

Data availability

The data that support the findings of this study are available from Beijing Hospital, but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are however available from the corresponding author upon reasonable request.

Declarations

Ethics approval and consent to participate

The present study was performed in accordance with the Declaration of Helsinki and the research protocol was approved by the Ethical Committee of Beijing Hospital (2022BJYYEC-011-02). All the participants signed the informed consent.

Consent for publication

All the participants signed the written informed consent.

Competing interests

The authors declare no competing interests.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

1. Heidenreich PA Bozkurt B Aguilar D Allen LA Byun JJ Colvin MM Deswal A Drazner MH Dunlay SM Evers LR 2022 AHA/ACC/HFSA Guideline for the management of Heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice guidelines J Am Coll Cardiol 2022 79 17 e263 421 10.1016/j.jacc.2021.12.012 35379503
Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, et al. 2022 AHA/ACC/HFSA Guideline for the management of Heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice guidelines. J Am Coll Cardiol. 2022;79(17):e263–421.35379503
2. Tsao CW Aday AW Almarzooq ZI Anderson CAM Arora P Avery CL Baker-Smith CM Beaton AZ Boehme AK Buxton AE Heart Disease and Stroke Statistics-2023 update: a Report from the American Heart Association Circulation 2023 147 8 e93 621 10.1161/CIR.0000000000001123 36695182
Tsao CW, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, Baker-Smith CM, Beaton AZ, Boehme AK, Buxton AE, et al. Heart Disease and Stroke Statistics-2023 update: a Report from the American Heart Association. Circulation. 2023;147(8):e93–621.36695182
3. Mozaffarian D Benjamin EJ Go AS Arnett DK Blaha MJ Cushman M de Ferranti S Després JP Fullerton HJ Howard VJ Heart disease and stroke statistics–2015 update: a report from the American Heart Association Circulation 2015 131 4 e29 322 25520374
Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, de Ferranti S, Després JP, Fullerton HJ, Howard VJ, et al. Heart disease and stroke statistics–2015 update: a report from the American Heart Association. Circulation. 2015;131(4):e29–322.25520374
4. Hao G Wang X Chen Z Zhang L Zhang Y Wei B Zheng C Kang Y Jiang L Zhu Z Prevalence of heart failure and left ventricular dysfunction in China: the China Hypertension Survey, 2012–2015 Eur J Heart Fail 2019 21 11 1329 37 10.1002/ejhf.1629 31746111
Hao G, Wang X, Chen Z, Zhang L, Zhang Y, Wei B, Zheng C, Kang Y, Jiang L, Zhu Z, et al. Prevalence of heart failure and left ventricular dysfunction in China: the China Hypertension Survey, 2012–2015. Eur J Heart Fail. 2019;21(11):1329–37.31746111
5. Society of Cardiology CMA Retrospective investigation of hospitalized patients with heart failure in some parts of China in 1980, 1990 and 2000 Chin J Cardiol 2002 30 8 450 4
Society of Cardiology CMA. Retrospective investigation of hospitalized patients with heart failure in some parts of China in 1980, 1990 and 2000. Chin J Cardiol. 2002;30(8):450–4.
6. Society of Cardiology CMA. Chinese guidelines for diagnosis and treatment of heart failure 2018. Chin J Cardiol 2018, 46(10).
7. Geriatrics EaCFBoCSo Committee AoCHFCE: Chinese expert consensus on early screening and primary prevention of heart failure (2024) Chin J Gen Pract 2024 23 1 7 18
Geriatrics, EaCFBoCSo. Committee AoCHFCE: Chinese expert consensus on early screening and primary prevention of heart failure (2024). Chin J Gen Pract. 2024;23(1):7–18.
8. Ponikowski P Voors AA Anker SD Bueno H Cleland JG Coats AJ Falk V González-Juanatey JR Harjola VP Jankowska EA 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC Eur J Heart Fail 2016 18 8 891 975 10.1002/ejhf.592 27207191
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18(8):891–975.27207191
9. Liu S Li J Wan DY Li R Qu Z Hu Y Liu J Effectiveness of eHealth Self-management interventions in patients with heart failure: systematic review and Meta-analysis J Med Internet Res 2022 24 9 e38697 10.2196/38697 36155484
Liu S, Li J, Wan DY, Li R, Qu Z, Hu Y, Liu J. Effectiveness of eHealth Self-management interventions in patients with heart failure: systematic review and Meta-analysis. J Med Internet Res. 2022;24(9):e38697.36155484
10. Fradette M Bungard TJ Simpson SH Tsuyuki RT Development of educational materials for congestive-heart-failure patients Am J Health Syst Pharm 2004 61 4 386 9 10.1093/ajhp/61.4.386 15011767
Fradette M, Bungard TJ, Simpson SH, Tsuyuki RT. Development of educational materials for congestive-heart-failure patients. Am J Health Syst Pharm. 2004;61(4):386–9.15011767
11. Collier L Home management of heart failure based solely on symptom and fluid management, adherence and knowledge may not fully meet the complex needs of patients Evid Based Nurs 2019 22 2 46 10.1136/ebnurs-2018-103014 30902825
Collier L. Home management of heart failure based solely on symptom and fluid management, adherence and knowledge may not fully meet the complex needs of patients. Evid Based Nurs. 2019;22(2):46.30902825
12. Lancey A, Slater CE. Heart failure self-management: a scoping review of interventions implemented by allied health professionals. Disabil Rehabil 2023:1–12.
13. Miller WL Measurement of blood volume in patients with heart failure: clinical relevance, surrogates, historical background and contemporary methodology Heart Int 2023 17 1 36 43 10.17925/HI.2023.17.1.36 37456346
Miller WL. Measurement of blood volume in patients with heart failure: clinical relevance, surrogates, historical background and contemporary methodology. Heart Int. 2023;17(1):36–43.37456346
14. Middel B Bouma J de Jongste M van Sonderen E Niemeijer MG Crijns H van den Heuvel W Psychometric properties of the Minnesota living with heart failure questionnaire (MLHF-Q) Clin Rehabil 2001 15 5 489 500 10.1191/026921501680425216 11594639
Middel B, Bouma J, de Jongste M, van Sonderen E, Niemeijer MG, Crijns H, van den Heuvel W. Psychometric properties of the Minnesota living with heart failure questionnaire (MLHF-Q). Clin Rehabil. 2001;15(5):489–500.11594639
15. Buysse DJ Reynolds CF Monk TH Berman SR Kupfer DJ The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research Psychiatry Res 1989 28 2 193 213 10.1016/0165-1781(89)90047-4 2748771
Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–213.2748771
16. Zung WW A rating instrument for anxiety disorders Psychosomatics 1971 12 6 371 9 10.1016/S0033-3182(71)71479-0 5172928
Zung WW. A rating instrument for anxiety disorders. Psychosomatics. 1971;12(6):371–9.5172928
17. Zung WW The Depression Status Inventory: an adjunct to the Self-Rating Depression Scale J Clin Psychol 1972 28 4 539 43 10.1002/1097-4679(197210)28:4<539::AID-JCLP2270280427>3.0.CO;2-S 5080837
Zung WW. The Depression Status Inventory: an adjunct to the Self-Rating Depression Scale. J Clin Psychol. 1972;28(4):539–43.5080837
18. Meng Y Zhuge W Huang H Zhang T Ge X The effects of early exercise on cardiac rehabilitation-related outcome in acute heart failure patients: a systematic review and meta-analysis Int J Nurs Stud 2022 130 104237 10.1016/j.ijnurstu.2022.104237 35421772
Meng Y, Zhuge W, Huang H, Zhang T, Ge X. The effects of early exercise on cardiac rehabilitation-related outcome in acute heart failure patients: a systematic review and meta-analysis. Int J Nurs Stud. 2022;130:104237.35421772
19. Tawalbeh LI The Effect of Cardiac Education on Knowledge and Self-Care behaviors among patients with heart failure Dimens Crit Care Nurs 2018 37 2 78 86 10.1097/DCC.0000000000000285 29381502
Tawalbeh LI. The Effect of Cardiac Education on Knowledge and Self-Care behaviors among patients with heart failure. Dimens Crit Care Nurs. 2018;37(2):78–86.29381502
20. Tinoco J Figueiredo LDS Flores PVP Padua BLR Mesquita ET Cavalcanti ACD Effectiveness of health education in the self-care and adherence of patients with heart failure: a meta-analysis Rev Lat Am Enfermagem 2021 29 e3389 10.1590/1518.8345.4281.3389 34287537
Tinoco J, Figueiredo LDS, Flores PVP, Padua BLR, Mesquita ET, Cavalcanti ACD. Effectiveness of health education in the self-care and adherence of patients with heart failure: a meta-analysis. Rev Lat Am Enfermagem. 2021;29:e3389.34287537
21. Habibzadeh H Shariati A Mohammadi F Babayi S The effect of educational intervention based on Pender’s health promotion model on quality of life and health promotion in patients with heart failure: an experimental study BMC Cardiovasc Disord 2021 21 1 478 10.1186/s12872-021-02294-x 34610821
Habibzadeh H, Shariati A, Mohammadi F, Babayi S. The effect of educational intervention based on Pender’s health promotion model on quality of life and health promotion in patients with heart failure: an experimental study. BMC Cardiovasc Disord. 2021;21(1):478.34610821
22. Yu DS Li PW Li SX Smith RD Yue SC Yan BPY Effectiveness and cost-effectiveness of an Empowerment-Based Self-Care Education Program on Health outcomes among patients with heart failure: a Randomized Clinical Trial JAMA Netw Open 2022 5 4 e225982 10.1001/jamanetworkopen.2022.5982 35380643
Yu DS, Li PW, Li SX, Smith RD, Yue SC, Yan BPY. Effectiveness and cost-effectiveness of an Empowerment-Based Self-Care Education Program on Health outcomes among patients with heart failure: a Randomized Clinical Trial. JAMA Netw Open. 2022;5(4):e225982.35380643
23. Artinian NT Magnan M Sloan M Lange MP Self-care behaviors among patients with heart failure Heart Lung 2002 31 3 161 72 10.1067/mhl.2002.123672 12011807
Artinian NT, Magnan M, Sloan M, Lange MP. Self-care behaviors among patients with heart failure. Heart Lung. 2002;31(3):161–72.12011807
24. Pack QR Squires RW Lopez-Jimenez F Lichtman SW Rodriguez-Escudero JP Lindenauer PK Thomas RJ Participation rates, process monitoring, and Quality Improvement among Cardiac Rehabilitation Programs in the United States: a NATIONAL SURVEY J Cardiopulm Rehabil Prev 2015 35 3 173 80 10.1097/HCR.0000000000000108 25763922
Pack QR, Squires RW, Lopez-Jimenez F, Lichtman SW, Rodriguez-Escudero JP, Lindenauer PK, Thomas RJ. Participation rates, process monitoring, and Quality Improvement among Cardiac Rehabilitation Programs in the United States: a NATIONAL SURVEY. J Cardiopulm Rehabil Prev. 2015;35(3):173–80.25763922
25. Miller WL Fluid volume overload and congestion in Heart failure: time to reconsider pathophysiology and how volume is assessed Circ Heart Fail 2016 9 8 e002922 10.1161/CIRCHEARTFAILURE.115.002922 27436837
Miller WL. Fluid volume overload and congestion in Heart failure: time to reconsider pathophysiology and how volume is assessed. Circ Heart Fail. 2016;9(8):e002922.27436837
26. Johansson P van der Wal MH Strömberg A Waldréus N Jaarsma T Fluid restriction in patients with heart failure: how should we think? Eur J Cardiovasc Nurs 2016 15 5 301 4 10.1177/1474515116650346 27169459
Johansson P, van der Wal MH, Strömberg A, Waldréus N, Jaarsma T. Fluid restriction in patients with heart failure: how should we think? Eur J Cardiovasc Nurs. 2016;15(5):301–4.27169459
27. Zhao Q Chen C Zhang J Ye Y Fan X Effects of self-management interventions on heart failure: systematic review and meta-analysis of randomized controlled trials Int J Nurs Stud 2020 110 103689 10.1016/j.ijnurstu.2020.103689 32679402
Zhao Q, Chen C, Zhang J, Ye Y, Fan X. Effects of self-management interventions on heart failure: systematic review and meta-analysis of randomized controlled trials. Int J Nurs Stud. 2020;110:103689.32679402
28. Feng C Wang Y Li S Qu Z Zheng S Effect of self-management intervention on prognosis of patients with chronic heart failure: a meta-analysis Nurs Open 2023 10 4 2015 29 10.1002/nop2.1489 36403127
Feng C, Wang Y, Li S, Qu Z, Zheng S. Effect of self-management intervention on prognosis of patients with chronic heart failure: a meta-analysis. Nurs Open. 2023;10(4):2015–29.36403127
29. Wakefield BJ Boren SA Groves PS Conn VS Heart failure care management programs: a review of study interventions and meta-analysis of outcomes J Cardiovasc Nurs 2013 28 1 8 19 10.1097/JCN.0b013e318239f9e1 22343208
Wakefield BJ, Boren SA, Groves PS, Conn VS. Heart failure care management programs: a review of study interventions and meta-analysis of outcomes. J Cardiovasc Nurs. 2013;28(1):8–19.22343208
30. Parati G Lombardi C Castagna F Mattaliano P Filardi PP Agostoni P Italian Society of Cardiology Working Group on Heart failure m: heart failure and sleep disorders Nat Rev Cardiol 2016 13 7 389 403 10.1038/nrcardio.2016.71 27173772
Parati G, Lombardi C, Castagna F, Mattaliano P, Filardi PP, Agostoni P. Italian Society of Cardiology Working Group on Heart failure m: heart failure and sleep disorders. Nat Rev Cardiol. 2016;13(7):389–403.27173772
31. Redeker NS, Yaggi HK, Jacoby D, Hollenbeak CS, Breazeale S, Conley S, Hwang Y, Iennaco J, Linsky S, Nwanaji-Enwerem U et al. Cognitive behavioral therapy for insomnia has sustained effects on insomnia, fatigue, and function among people with chronic heart failure and insomnia: the HeartSleep Study. Sleep 2022, 45(1).
32. Redeker NS Jeon S Andrews L Cline J Mohsenin V Jacoby D Effects of cognitive behavioral therapy for Insomnia on Sleep-related cognitions among patients with stable heart failure Behav Sleep Med 2019 17 3 342 54 10.1080/15402002.2017.1357120 28745520
Redeker NS, Jeon S, Andrews L, Cline J, Mohsenin V, Jacoby D. Effects of cognitive behavioral therapy for Insomnia on Sleep-related cognitions among patients with stable heart failure. Behav Sleep Med. 2019;17(3):342–54.28745520
33. Redeker NS Conley S O’Connell M Geer JH Yaggi H Jeon S Sleep-related predictors of cognition among adults with chronic insomnia and heart failure enrolled in a randomized controlled trial of cognitive behavioral therapy for insomnia J Clin Sleep Med 2023 19 6 1073 81 10.5664/jcsm.10498 36740924
Redeker NS, Conley S, O’Connell M, Geer JH, Yaggi H, Jeon S. Sleep-related predictors of cognition among adults with chronic insomnia and heart failure enrolled in a randomized controlled trial of cognitive behavioral therapy for insomnia. J Clin Sleep Med. 2023;19(6):1073–81.36740924
34. Sin DD Logan AG Fitzgerald FS Liu PP Bradley TD Effects of continuous positive Airway pressure on Cardiovascular outcomes in Heart failure patients with and without Cheyne-Stokes respiration Circulation 2000 102 1 61 6 10.1161/01.CIR.102.1.61 10880416
Sin DD, Logan AG, Fitzgerald FS, Liu PP, Bradley TD. Effects of continuous positive Airway pressure on Cardiovascular outcomes in Heart failure patients with and without Cheyne-Stokes respiration. Circulation. 2000;102(1):61–6.10880416
35. Kaneko Y Floras JS Usui K Plante J Tkacova R Kubo T Ando S-i Bradley TD Cardiovascular effects of continuous positive Airway pressure in patients with heart failure and obstructive sleep apnea N Engl J Med 2003 348 13 1233 41 10.1056/NEJMoa022479 12660387
Kaneko Y, Floras JS, Usui K, Plante J, Tkacova R, Kubo T, Ando S-i, Bradley TD. Cardiovascular effects of continuous positive Airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med. 2003;348(13):1233–41.12660387
36. Rutledge T Reis VA Linke SE Greenberg BH Mills PJ Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes J Am Coll Cardiol 2006 48 8 1527 37 10.1016/j.jacc.2006.06.055 17045884
Rutledge T, Reis VA, Linke SE, Greenberg BH, Mills PJ. Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol. 2006;48(8):1527–37.17045884
37. Sbolli M Fiuzat M Cani D O’Connor CM Depression and heart failure: the lonely comorbidity Eur J Heart Fail 2020 22 11 2007 17 10.1002/ejhf.1865 32468714
Sbolli M, Fiuzat M, Cani D, O’Connor CM. Depression and heart failure: the lonely comorbidity. Eur J Heart Fail. 2020;22(11):2007–17.32468714
38. Celano CM Mastromauro CA Lenihan EC Januzzi JL Rollman BL Huffman JC Association of baseline anxiety with depression persistence at 6 months in patients with acute cardiac illness Psychosom Med 2012 74 1 93 9 10.1097/PSY.0b013e31823d3d38bc 22210240
Celano CM, Mastromauro CA, Lenihan EC, Januzzi JL, Rollman BL, Huffman JC. Association of baseline anxiety with depression persistence at 6 months in patients with acute cardiac illness. Psychosom Med. 2012;74(1):93–9.22210240
39. Vieweg WV Julius DA Fernandez A Wulsin LR Mohanty PK Beatty-Brooks M Hasnain M Pandurangi AK Treatment of depression in patients with coronary heart disease Am J Med 2006 119 7 567 73 10.1016/j.amjmed.2006.02.037 16828625
Vieweg WV, Julius DA, Fernandez A, Wulsin LR, Mohanty PK, Beatty-Brooks M, Hasnain M, Pandurangi AK. Treatment of depression in patients with coronary heart disease. Am J Med. 2006;119(7):567–73.16828625
